COVID-19, Cardiovascular Diseases and Cardiac Troponins
Key result
Elevated cardiac troponin marks myocardial injury and predicts worse clinical outcomes in COVID-19 patients.
Why the study?
Myocardial injury in COVID-19 patients with elevated cardiac troponin has been observed, but the exact mechanisms and prognostic utility remain unclear.
Population
COVID-19 patients
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Myocardial injury mechanisms in COVID-19 with elevated cTn remain unclear; leaves open targeted studies to clarify dominant pathways.
Structured PICO
P
Population
COVID-19 patients
O
Outcome
Utility of cardiac troponin (cTn) as a biomarker for measuring myocardial injury and as a prognostic factor for clinical outcomesurrogate
This review highlights the mechanisms of myocardial injury in COVID-19 and underscores the prognostic utility of cardiac troponin in these patients.
Cite This Study
Kim et al. (2021) conducted a review in COVID-19. Cardiac troponins was evaluated. Elevated cardiac troponin in COVID-19 patients indicates myocardial injury and serves as a prognostic biomarker for clinical outcomes, driven by mechanisms like viral invasion and cytokine storm.